What Approaches Can Companies Use to Create Drugs with Disease-Modifying Effects and to Treat Early-Stage Disease?
Business Wire via Yahoo! Finance Mon, 04 Dec 2006 6:31 AM PST
DUBLIN, Ireland----Research and Markets has announced the addition of the Decision Resources report "Industry Analysis: Where Is the Innovation in Neurology Markets?" to their offering.

---

Protein Linked to MS Relapse
WebMD Mon, 04 Dec 2006 9:48 AM PST
A protein abundant in multiple sclerosis (MS) patients during disease flare-ups may be a key culprit in this and other autoimmune diseases.

Molecule Linked to Autoimmune Disease Relapses Identified at Stanford RedNova Sun, 03 Dec 2006 3:25 PM PST The ebb and flow of such autoimmune diseases as multiple sclerosis, lupus and rheumatoid arthritis has long been a perplexing mystery.

Molecule Linked to Autoimmune Disease Relapses Identified at Stanford
Business Wire via Yahoo! Finance Sun, 03 Dec 2006 11:00 AM PST
STANFORD, Calif.----The ebb and flow of such autoimmune diseases as multiple sclerosis, lupus and rheumatoid arthritis has long been a perplexing mystery. But new findings from the Stanford University School of Medicine bring scientists closer to solving the puzzle, identifying a molecule that appears to play a central role in relapses.